YDES — YD BIO LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 13 SEC-registered investment managers reported holding YDES (YD BIO LTD) in their latest 13F filings, with a combined reported value of $3.80M across 512.24K shares. That is +51.5% by share count (+127.50K shares) versus the previous quarter, while reported value moved +399.7%. Ownership is concentrated: the five largest holders account for 71.7% of reported value and the top ten for 99.9%.
Compared with the prior quarter, 5 opened new positions, 4 added to existing stakes, 2 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of YD BIO LTD (YDES) include Cerity Partners LLC, Garrett Wealth Advisory Group, LLC, JANE STREET GROUP, LLC, ranked by reported 13F value among the 23 institutional holders on this page.
YDES is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 13 | 512.24K | $3.80M | +51.5% |
| Q2 2026 | 13 | 346.97K | $780.68K | +10.5% |
| Q1 2026 | 8 | 159.52K | $1.23M | +14.1% |
| Q4 2025 | 10 | 141.58K | $1.73M | -7.5% |
| Q3 2025 | 10 | 175.51K | $3.42M | — |
Over the 5 quarters shown, institutional share counts increased 192% in aggregate (Q3 2025 → Q3 2026); the largest single-quarter swing was Q1 2026 (+14.1%).
Top Institutional Holders (Q3 2026) — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 107.41K | $796.95K | 0.00% | Add | |
| 84.63K | $627.96K | 0.10% | Hold | |
| 78.32K | $581.15K | 0.00% | Add | |
| 48.55K | $360.21K | 0.00% | New | |
| 48.55K | $360.21K | 0.00% | New | |
| 44.94K | $333.47K | 0.00% | Reduce | |
| 29.97K | $222.38K | 0.18% | Reduce | |
| 29.09K | $215.82K | 0.00% | Add | |
| 21.84K | $162.00K | 0.00% | New | |
| 18.32K | $135.94K | 0.00% | New | |
| 549 | $4.07K | 0.00% | Add | |
| 75 | $557 | 0.00% | Hold | |
| 5 | $38 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 13 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 84.63K | $190.42K | 0.03% | New | |
| 62.71K | $141.11K | 0.00% | New | |
| 62.71K | $141.11K | 0.00% | Add | |
| 33.69K | $75.80K | 0.06% | Add | |
| 32.41K | $72.91K | 0.00% | Hold | |
| 30.11K | $67.74K | 0.00% | Add | |
| 21.42K | $48.20K | 0.00% | New | |
| 12.38K | $27.86K | 0.00% | Add | |
| 4.89K | $10.99K | 0.00% | Hold | |
| 1.78K | $4.00K | 0.00% | New | |
| 160 | $360 | 0.00% | Reduce | |
| 75 | $169 | 0.00% | New | |
| 1 | $2 | 0.00% | Hold |
Q1 2026 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 60.24K | $463.82K | 0.00% | Add | |
| 32.41K | $249.53K | 0.00% | Hold | |
| 30.69K | $236.31K | 0.22% | Add | |
| 19.45K | $149.76K | 0.00% | Add | |
| 11.63K | $89.54K | 0.00% | Add | |
| 4.89K | $37.62K | 0.00% | Add | |
| 223 | $1.72K | 0.00% | Reduce | |
| 1 | $8 | 0.00% | Hold |
Q4 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 58.36K | $711.44K | 0.00% | Add | |
| 32.41K | $395.03K | 0.00% | Hold | |
| 27.54K | $335.71K | 0.31% | Reduce | |
| 11.55K | $140.78K | 0.00% | New | |
| 7.19K | $87.67K | 0.00% | Reduce | |
| 2.52K | $30.67K | 0.00% | New | |
| 1.71K | $20.83K | 0.00% | New | |
| 299 | $3.65K | 0.00% | Reduce | |
| 5 | $61 | 0.00% | New | |
| 1 | $12 | 0.00% | Hold |
Q3 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 53.07K | $1.03M | 0.00% | New | |
| 32.41K | $630.95K | 0.00% | New | |
| 31.82K | $619.00K | 0.00% | New | |
| 29.99K | $583.90K | 0.54% | New | |
| 10.32K | $200.85K | 0.00% | New | |
| 10.26K | $199.70K | 0.00% | New | |
| 7.50K | $146.03K | 0.00% | New | |
| 90 | $1.75K | 0.00% | New | |
| 58 | $1.13K | 0.00% | New | |
| 1 | $19 | 0.00% | New |
New Positions (Q3 2026)
- MILLENNIUM MANAGEMENT LLC 48.55K sh · $360.21K
- Millennium Management 48.55K sh · $360.21K
- HRT FINANCIAL LP 21.84K sh · $162.00K
- XTX Topco Ltd 18.32K sh · $135.94K
- JPMorgan Chase & Co 5 sh · $38
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 62.71K sh · $141.11K
- Citadel Advisors sold 30.11K sh · $67.74K
- WOLVERINE ASSET MANAGEMENT LLC sold 4.89K sh · $10.99K
- SkyView Investment Advisors, LLC sold 1.78K sh · $4.00K
- Fidelity Management & Research (FMR) sold 1 sh · $2
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Cerity Partners LLC | 107.41K | 32.41K | 32.41K | 32.41K | 32.41K |
| Garrett Wealth Advisory Group, LLC | 84.63K | 84.63K | — | — | — |
| JANE STREET GROUP, LLC | 78.32K | 21.42K | — | — | — |
| MILLENNIUM MANAGEMENT LLC | 48.55K | — | — | — | — |
| Millennium Management | 48.55K | — | — | — | — |
| Geode Capital Management | 44.94K | 62.71K | 60.24K | 58.36K | 53.07K |
| Cypress Capital Management LLC (WY) | 29.97K | 33.69K | 30.69K | 27.54K | 29.99K |
| UBS Group AG | 29.09K | 12.38K | 11.63K | 7.19K | 10.32K |
| HRT FINANCIAL LP | 21.84K | — | — | — | 31.82K |
| XTX Topco Ltd | 18.32K | — | — | — | — |
| Morgan Stanley | 549 | 160 | 223 | 299 | 10.26K |
| Wells Fargo & Co | 75 | 75 | — | — | — |
| JPMorgan Chase & Co | 5 | — | — | — | — |
| Citadel Advisors | — | 30.11K | 19.45K | 11.55K | — |
| Clear Street Group Inc. | — | — | — | — | 7.50K |
| GEODE CAPITAL MANAGEMENT, LLC | — | 62.71K | — | — | — |
| WOLVERINE ASSET MANAGEMENT LLC | — | 4.89K | 4.89K | 2.52K | — |
| Citigroup Inc | — | — | — | 1.71K | — |
| SkyView Investment Advisors, LLC | — | 1.78K | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | — | — | — | — | 90 |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold YDES?
As of 2026-Q3, 13 institutional funds reported holding YDES (YD BIO LTD) in SEC 13F filings, with a combined reported value of $3.80M.
How many shares of YDES do institutions own?
13F filers reported 512.24K shares of YDES, worth $3.80M in aggregate at the end of 2026-Q3.
Is institutional ownership of YDES rising or falling?
Share counts moved +51.5% versus the prior quarter — accumulation.
Who are the top institutional holders of YDES?
The largest 13F holders are Cerity Partners LLC, Garrett Wealth Advisory Group, LLC, JANE STREET GROUP, LLC, MILLENNIUM MANAGEMENT LLC, Millennium Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of YD BIO LTD?
The major shareholders of YD BIO LTD (YDES) by reported 13F value are Cerity Partners LLC, Garrett Wealth Advisory Group, LLC, JANE STREET GROUP, LLC, MILLENNIUM MANAGEMENT LLC, Millennium Management, among 23 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.